Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-053-4 | CAS number: 18169-57-8
Endpoint summary
Administrative data
Description of key information
No repeat-dose toxicity data are available for trichloroisobutylsilane, therefore good quality data have been read across from the related substance triethoxyisobutylsilane. The key repeated dose toxicity study was a 90-day nose-only inhalation study conducted in male and female rats, according to OECD 413. The study identified a NOAEC value of at least 2.54 mg/l (measured concentration), which was the highest dose tested. There were no significant treatment-related effects.
Key value for chemical safety assessment
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 2 540 mg/m³
Additional information
The key study for repeated dose toxicity is the only reliable study for this endpoint, based on read-across from the related substance triethoxyisobutylsilane(CAS 17980 -47 -1). The registered substance, trichloroisobutylsilane, and the surrogate substance both hydrolyse in contact with water to produce the common hydrolysis product isobutylsilanetriol, with the other hydrolysis products being hydrogen chloride and ethanol respectively. Although at pH 7, the triethoxy analogue hydrolyses more slowly than the trichloro (half-life 22 hours compared to <1 minute), under acidic conditions such as in the stomach following oral ingestion, the triethoxy substance is expected to hydrolyse rapidly, based on experience with other ethoxy silanes.
Since both substances generate a common hydrolysis product, in the absence of other data it is considered appropriate to read-across the result of the reliable OECD 413 test for the inhalation route. However, uptake in the lungs is likely to be significantly greater for the triethoxy analogue (log Kow 3.6) than for the trichlorosilane or silanetriol. The NOAEC for the triethoxy analogue is therefore likely to be conservative for the inhalation route. At the dose levels relevant for testing and human exposure, ethanol generated in vivo would not contribute any systemic toxicity effects.
Hydrogen chloride, generated by hydrolysis of trichloroisobutylsilane can be expected to cause local irritant or corrosive effects at sufficiently high concentrations. These effects are not addressed by the read-across data.
Justification for classification or non-classification
The available data do not support classification under Regulation (EC) No 1272/2008 or Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
